NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 4.72% |
| UCB | UCB SA | Healthcare | Biotechnology | 3.63% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.35% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 3.10% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.03% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.81% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.74% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.65% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 2.63% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.37% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.33% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.32% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.30% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.19% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.07% |
| KYMR | Kymera Therapeutics Inc | Healthcare | Biotechnology | 2.00% |
| CAI | Caris Life Sciences, Inc. Common Stock | Healthcare | Biotechnology | 2.00% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| HTFL | Heartflow, Inc. Common Stock | Healthcare | Health Information Services | 1.85% |